Medical AI in South Korea, recognized by the world, seeking to enter the Asia market to turn away from the low demand and high domestic regulations

November 19, 2018

DEEPNOID prepares to enter the Chinese market with 'DEEP: PHI,' an AI solution for medical image diagnosis support. Recently, DEEP: PHI is going through approval as a medical device under the Korea Food and Drug Administration. Embedded solutions include AI in compression fracture and cerebral aneurysm.


as soon as obtaining the medical device license, DEEP: PHI will expand onto China. The Alibaba cloud has completed its technical review to install in DEEP: PHI on their system. As early as the second quarter next year, DEEP: PHI will be supplied selectively to Alibaba-cooperated hospitals.


Share on Facebook
Share on Twitter
Please reload

Featured Posts

"근골격계질환 의료AI로 2021년 미국 시장 진출하겠다"

June 10, 2019

Please reload

Recent Posts
Please reload


©2019 DEEPNOID Inc.